Tough bill on gifts takes aim at 'industry kickbacks,' advertising deductions

Share this article:
A bill introduced in the House of Representatives last week would mandate reporting of all gifts to physicians worth more than $25, and violators could lose millions in tax deductions for advertising expenses.

The Physician Payments Sunshine Act of 2008, or H. R. 5605, could require quarterly reporting of product rebates, dividends, education, funded research, funded research, food, trips and travel, consulting fees, rebates, dividends and more over the value of $25,transferred to physicians by drug, device and medical supply companies or by third parties acting on their behalf. That information – who got what from whom – would be made publicly available. The bill would impose fines of $10,000 to $100,000 per violation, and if a company failed to report a single gift over $25, it would lose its tax deductions on all advertising-related expenses for that year.
A similar bill, S. 2029, is moving through the Senate.

The House bill, authored by Rep. Peter DeFazio (D-OR), has a powerful co-sponsor in Ways and Means Health Subcommittee Chairman Pete Stark (D-CA). The Senate bill was introduced by Sens. Chuck Grassley (R-IA), ranking member and former chair of the Senate Finance Committee, and Herb Kohl (D-WI), chair of the Special Committee on Aging.

“Americans are being gouged by pharmaceutical companies that spend more on marketing than they do on research and development,” said DeFazio in a statement. Stark added: “Patients deserve to know if doctors are on the take. Gifts and payments change doctors' behavior. If they didn't, drug, device and medical supply companies wouldn't bother. The Sunshine Act will help enable Medicare beneficiaries to determine if their doctors are acting in patients' best interests. It may even convince doctors to quit taking what can only be described as industry kickbacks.”
Share this article:

Email Newsletters

More in News

Meaningful use not linked to quality: study

Meaningful use not linked to quality: study

A recent study of physicians found no correlation between following EHR meaningful use requirements and providing consistently higher quality of care.

Lilly Q1 sales dip

Lilly Q1 sales dip

US sales fell 34% during the quarter, largely due to lower demand and lower prices for off-patent Cymbalta and Evista.

Gilead reaps huge HCV sales, payer fury

Gilead reaps huge HCV sales, payer fury

Sovaldi's debut has been marked by plenty of criticism from payers and lawmakers, but the hep. C drug's launch, now confirmed to be the fastest of all time, has also ...